微创食管切除术治疗食管癌的研究进展

doi:10.3877/cma.j.issn.1674-6899.2020.01.014

食管癌是全世界8大常见恶性肿瘤之一，外科手术仍为最主要的治疗方案。传统开放食管切除术术后并发症发生率高，患者生活质量较差。为减少手术并发症、提高患者的生活质量，微创食管切除术逐渐被胸外科医师接受并应用于食管癌的治疗当中。目前，多数研究认为微创食管切除术是安全、可行的，同时术后并发症发生率等短期效果优于开放食管切除术，而总生存率等远期效果并不低于开放食管切除术。随着研究的不断细化深入，食管癌的精准微创治疗将得到进一步的发展和推广。

关键词: 食管癌, 微创手术, 食管切除术

Esophageal cancer is one of the eight common malignant tumors in the world and surgical therapy is still the most important treatment. Traditional open esophagectomy has a high morbidity of postoperative complications and patients have poor quality of life. In order to reduce the postoperative complications and improve the quality of life of patients, minimally invasive esophagectomy is gradually accepted by thoracic surgeons and applied to the treatment of esophageal cancer. Most studies believe that minimally invasive esophagectomy is a safe and feasible method. At the same time, the short-term effect such as the morbidity of postoperative complications is better than open esophagectomy and the long-term effect like overall survival is not lower than open esophagectomy. The precise minimally invasive treatment of esophageal cancer will be further developed and promoted.

Key words: Esophageal cancer, Minimally invasive surgery, Esophagectomy

1	Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Lancet, 2013, 381(9864): 400-412.
2	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012 [J]. International journal of cancer, 2015, 136(5): 359-386.
3	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA: a cancer journal for clinicians, 2019, 69(1): 7-34.
4	Zhao Q, Yu J, Meng X. A good start of immunotherapy in esophageal cancer [J]. Cancer medicine, 2019, 8(10): 4519-4526.
5	Kelly RJ. The emerging role of immunotherapy for esophageal cancer[J]. Current opinion in gastroenterology, 2019, 35(4):337-343.
6	Straatman J, Wielen N, cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the time trial[J]. Ann Surg, 2017, 266(2): 232-236.
7	Biere SS, Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J]. Lancet, 2012, 379(9829): 1887-1892.
8	Dallemagne B, Weerts JM, Jehaes C, et al. Laparoscopic nissen fundoplication: preliminary report [J]. Surgical laparoscopy & endoscopy, 1991, 1(3): 138-143.
9	Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital[J]. Archives of surgery (Chicago, Ill: 1960), 2003, 138(7): 777-784.
10	Zhang YC, Wu QB, Yang XY, et al. Laparoscopic-assisted transhiatal esophagogastrectomy without thoracic or cervical access: a series of one hundred three consecutive cases[J]. Journal of laparoendoscopic & advanced surgical techniques Part A, 2018，28(7): 845-852.
11	陈克能，马少华，梁震，等．经膈肌裂孔食管切除术治疗食管癌及食管胃交界癌的远期疗效[J]．中华胃肠外科杂志，2010，13(9):649-651.
12	Mir MR, Lashkari M, Ghalehtaki R, et al. Transhiatal versus left transthoracic esophagectomy for gastroesophageal junction cancer; the impact of surgical approach on postoperative complications[J]. Middle East journal of digestive diseases, 2019, 11(2): 104-109.
13	Lee Y, Min SH, Park KB, et al. Long-term outcomes of laparoscopic versus open transhiatal approach for the treatment of esophagogastric junction cancer [J]. Journal of gastric cancer, 2019, 19(1): 62-71.
14	Dunn DH, Johnson EM, Anderson CA, et al. Operative and survival outcomes in a series of 100 consecutive cases of robot-assisted transhiatal esophagectomies [J]. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2017, 30(10): 1-7.
15	李尘宸，吴汉然，邓杰，等. 微创Ivor-Lewis食管切除术与开放Ivor-Lewis食管切除术治疗胸中下段食管癌的疗效对比[J]. 中国临床保健杂志，2017, 20(6): 689-692.
16	Wang Q, Wu Z, Zhan T, et al. Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis [J]. BMC cancer, 2019, 19(1): 500-500.
17	张亚杰，韩宇，项捷，等. 机器人微创Ivor Lewis食管癌根治术的应用[J]. 中国胸心血管外科临床杂志，2018, 25(9): 735-741.
18	金刚，朱自江，朱孔辉. 胸、腹腔镜联合McKeown食管癌根治术治疗中下段食管癌的临床研究[J]. 现代消化及介入诊疗，2018, 23(6): 756-758.
19	Shanmugasundaram R, Hopkins R, Neeman T, et al. Minimally invasive mckeown's vs open oesophagectomy for cancer: a meta-analysis[J]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2019, 45(6): 941-949.
20	Chiu PW, Teoh AY, Wong VW, et al. Robotic-assisted minimally invasive esophagectomy for treatment of esophageal carcinoma[J]. Journal of robotic surgery, 2017, 11(2): 193-199.
21	林涛，解明然，马冬春. 微创与开放Ivor Lewis食管切除术后急慢性疼痛对比研究 [J]. 中华肿瘤防治杂志，2019, 26(11): 784-789.
22	Maas KW, Biere SS, Hoogstraten IM, et al. Immunological changes after minimally invasive or conventional esophageal resection for cancer: a randomized trial [J]. World journal of surgery, 2014, 38(1): 131-137.
23	Sakamoto T, Fujiogi M, Matsui H, et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis [J]. Ann Surg, 2019.DOI： 10.1097/SLA.0000000000003500.
24	Mariette C, Markar SR, Dabakuyo-Yonli TS, et al. Hybrid minimally invasive esophagectomy for esophageal cancer[J]. The New England journal of medicine, 2019, 380(2): 152-162.
25	Campos JH. An update on robotic thoracic surgery and anesthesia[J]. Current opinion in anaesthesiology, 2010, 23(1): 1-6.
26	郭旭峰，李志刚. 机器人手术系统在多学科治疗模式下微创食管癌根治术中应用的思考[J]. 中国胸心血管外科临床杂志，2018, 25(8): 646-649.
27	Sluis PC, Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial[J]. Ann Surg, 2019, 269(4): 621-630.
28	Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer [J]. The New England journal of medicine, 1998, 339(27): 1979-1984.
29	Hulscher JB, Sandick JW, De Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus [J]. The New England journal of medicine, 2002, 347(21): 1662-1669.
30	Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort[J]. Ann Thorac Surg, 2003, 75(1): 217-222.
31	Seesing MFJ, Gisbertz SS, Goense L, et al. A propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the netherlands [J]．Ann Surg, 2017, 266(5): 839-846.
32	Seesing MFJ, Wijnhoven BPL. Response: "a propensity score－matched analysis of open versus minimally invasive transthoracic esophagectomy in the netherlands" [J]. Ann Surg, 2018, 268(6): 75-76.
33	Seesing MFJ, Wijnhoven BPL. Response to the comment on "a propensity score matched analysis of open versus minimally invasive transthoracic esophagectomy in the netherlands" [J]. Ann Surg, 2019, 269(4): 56-56.
34	何海权，林万里，张海，等. 单中心连续280例微创Mckeown术治疗食管癌经验[J]. 江西医药，2019, 54(4): 301-315.
35	周杰华，孔旭辉，黄秀芹. 食管癌手术患者住院费用影响因素研究[J]. 中国卫生标准管理，2018, 9(23): 19-22.
36	Dhamija A, Dhamija A, Hancock J, et al. Minimally invasive oesophagectomy more expensive than open despite shorter length of stay[J]. Eur J Cardiothorac Surg, 2014, 45(5): 904-909.
37	杨鲸蓉，徐驰，曾志勇，等. 食管癌微创治疗进展 [J]. 医学综述，2015, 21(16): 2923-2925.

[1]	张耀, 高峥嵘, 张强, 赵昌松, 陈佳敏, 赵汝岗, 马睿. 微创手术治疗18例布鲁菌病髋关节炎合并早期股骨头坏死的疗效[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(04): 281-287.
[2]	丁相元, 任效瑛, 闫慧明. 微创胰十二指肠切除术治疗胰腺导管腺癌围手术期和近远期疗效的Meta分析[J]. 中华普通外科学文献(电子版), 2021, 15(04): 313-320.
[3]	粟宇, 黄其密, 吕金莎. 食道支架置入术后合并肺部感染51例临床特征分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 527-529.
[4]	朱可安, 陈灵, 李昭, 黄薇. 应用单孔腹腔镜开展常见妇科手术的可行性探讨[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 158-162.
[5]	胡志豪, 李瑞欣, 王国俊. 食管胃结合部腺癌的微创外科治疗现状与展望[J]. 中华腔镜外科杂志(电子版), 2021, 14(03): 181-186.
[6]	朱中飞, 何天霖. 达芬奇机器人脾动脉瘤切除重建一例[J]. 中华腔镜外科杂志(电子版), 2021, 14(02): 112-115.
[7]	刘军强, 范博士, 龚太乾. 全腔镜Ivor-Lewis食管切除术治疗Siewert Ⅰ型食管胃结合部腺癌[J]. 中华腔镜外科杂志(电子版), 2021, 14(02): 127-128.
[8]	邱卫明, 王建荣, 徐志敏, 缪玖麟, 陈保华, 汪芝珍. LncRNA ZNF667-AS1靶向miR-31-5p对食管癌细胞增殖、迁移和凋亡的机制研究[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(01): 8-15.
[9]	中国医师协会结直肠肿瘤专业委员会NOTES专委会. 经自然腔道内镜手术（NOTES）专家共识[J]. 中华结直肠疾病电子杂志, 2021, 10(04): 337-342.
[10]	周军, 赵月明, 宋常华, 赵志明, 仲伟明, 邓昌武, 张聿民, 李树志. 神经内镜手术治疗自发性幕上中等程度脑出血的临床效果[J]. 中华神经创伤外科电子杂志, 2021, 07(01): 51-55.
[11]	苏欣宇, 严研, 姜倩, 夏建洪. 食管癌为第一原发癌的双原发癌患者预后分析[J]. 中华消化病与影像杂志(电子版), 2021, 11(03): 121-125.
[12]	周之伟, 王亮, 杨剑逸, 黄淼, 马则铭, 杨跃. 吻合口加固缝合对食管癌根治术后吻合口瘘发生的预防效果[J]. 中华临床医师杂志(电子版), 2021, 15(06): 407-411.
[13]	汪帅, 李红玲. 中性粒细胞/淋巴细胞比值、纤维蛋白原在食管癌诊断中的价值[J]. 中华临床医师杂志(电子版), 2021, 15(05): 365-369.
[14]	张嘉伟, 王健生, 张广健, 付军科, 屈航英, 张佳. 食管吻合口瘘动物模型研究进展[J]. 中华胸部外科电子杂志, 2021, 08(02): 101-107.
[15]	李志刚. 食管外科进展[J]. 中华胸部外科电子杂志, 2021, 08(02): 125-129.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Progress of minimally invasive esophagectomy for esophageal cancer

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Progress of minimally invasive esophagectomy for esophageal cancer